Nigrostriatal dopamine terminal imaging with dopamine transporter SPECT: an update
K Tatsch, G Poepperl - Journal of Nuclear Medicine, 2013 - Soc Nuclear Med
This article gives an update on nigrostriatal dopamine terminal imaging, with emphasis on
SPECT performed with the presynaptic dopamine transporter (DAT) ligand 123 I-FP-CIT. The …
SPECT performed with the presynaptic dopamine transporter (DAT) ligand 123 I-FP-CIT. The …
Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using 90Yttrium …
TF Jakobs, RT Hoffmann, G Poepperl, A Schmitz… - European …, 2007 - Springer
The purpose was to determine the response and survival and to analyse the feasibility of
single-session, whole-liver SIRT in patients with non-resectable, otherwise non-responding …
single-session, whole-liver SIRT in patients with non-resectable, otherwise non-responding …
Cortical hypometabolism and crossed cerebellar diaschisis suggest subcortically induced disconnection in CADASIL: an 18F-FDG PET study
K Tatsch, W Koch, R Linke, G Poepperl… - Journal of Nuclear …, 2003 - Soc Nuclear Med
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
(CADASIL) is an inherited small-vessel disease caused by mutations in the NOTCH3 gene…
(CADASIL) is an inherited small-vessel disease caused by mutations in the NOTCH3 gene…
Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy
HJ Reulen, G Poepperl, C Goetz, FJ Gildehaus… - Journal of …, 2015 - thejns.org
OBJECT The aim in this study was to present long-term results regarding overall survival (OS),
adverse effects, and toxicity following fractionated intracavitary radioimmunotherapy (RIT) …
adverse effects, and toxicity following fractionated intracavitary radioimmunotherapy (RIT) …
SERT and DAT availabilities under citalopram treatment in obsessive–compulsive disorder (OCD)
O Pogarell, G Poepperl, C Mulert, C Hamann… - European …, 2005 - Elsevier
Serotonin and dopamine transporter (SERT, DAT) availabilities have prospectively been
investigated using [ 123 I]β-CIT and single photon emission computed tomography in subjects …
investigated using [ 123 I]β-CIT and single photon emission computed tomography in subjects …
Value of O-(2-[{sup 18} F] fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent glioma
G Poepperl, FJ Gildehaus, K Tatsch, C Goetz… - European Journal of …, 2004 - osti.gov
The prognosis of patients with recurrent gliomas depends on reliable and early diagnosis of
tumour recurrence after initial therapy. In this context, magnetic resonance imaging (MRI) …
tumour recurrence after initial therapy. In this context, magnetic resonance imaging (MRI) …
FET PET for the evaluation of primary gliomas: Correlation of uptake and uptake kinetics with tumor histology
G Poepperl, F Kreth, J Herms, J Mehrkens, F Gildehaus… - 2007 - Soc Nuclear Med
34 Objectives: Treatment and prognosis of gliomas mainly depend on tumor aggressiveness
which is primarily determined by its histological tumor grade. Aim of the study was to …
which is primarily determined by its histological tumor grade. Aim of the study was to …
FET PET delineates malignant tumor parts within suspected WHO II gliomas
…, M Kunz, H Kretzschmar, P Bartenstein, G Poepperl - 2009 - Soc Nuclear Med
546 Objectives PET using [F-18]fluoroethyltyrosine (FET) often shows heterogeneous
findings in suspected WHO II gliomas. Whether intense FET uptake and suspicious kinetics …
findings in suspected WHO II gliomas. Whether intense FET uptake and suspicious kinetics …
[68Ga] DOTA-TATE-or [18F] DOPA-PET/CT: Which one is preferable for the diagnosis of neuroendocrine tumors (NET)?
…, P Bartenstein, R Tiling, B Waengler, G Poepperl - 2008 - Soc Nuclear Med
1548 Objectives: To compare the diagnostic value of [Ga-68]DOTA-TATE and [F-18]DOPA
PET/CT in well differentiated metastatic NET. Methods: PET/CT using both [Ga-68]DOTA-…
PET/CT in well differentiated metastatic NET. Methods: PET/CT using both [Ga-68]DOTA-…
Differentiation of idiopathic and non-idiopathic parkinsonian syndromes with [18F]-desmethoxyfallypride
610 Objectives The utility of the selective dopamine D2/3-receptor ligand [18F]-desmethoxyfallypride
(DMFP) for the differential diagnosis of patients with idiopathic parkinsonian …
(DMFP) for the differential diagnosis of patients with idiopathic parkinsonian …